Laviceftra 250mg Injection
Marketer
Lavish Biotech
Salt Composition
Ceftriaxone (250mg)
Overview Laviceftra 250mg Injection
Ceftolozane/tazobactam 250mg injection, a cephalosporin-class antibiotic, combats various bacterial infections. Its applications encompass infections affecting the brain (meningitis), lungs (pneumonia), ears, urinary tract, skin and soft tissues, bones and joints, bloodstream, and heart. Prophylactic use before surgery is also indicated. Administered intravenously (IV drip) or by intramuscular injection under medical supervision, dosage is determined by your physician. Regularly spaced doses, as prescribed, are crucial; completing the entire course is vital, even with symptom improvement, to prevent infection recurrence. Common side effects include diarrhea, rash, altered liver function tests, and atypical blood cell counts (e.g., eosinophilia, leukopenia, thrombocytopenia). Localized injection site redness or pain may occur temporarily. While usually mild, persistent or bothersome effects warrant medical attention. Prior to treatment, disclose any antibiotic allergies, kidney or liver conditions, and all other medications to your healthcare provider due to potential interactions.
Uses of Laviceftra 250mg Injection
Managing bacterial infections
Major Benefits of Laviceftra 250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Laviceftra 250mg Injection:
- Diarrhea
- Abnormal liver function tests
- Rash
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count
- Low blood platelets
How to use Laviceftra 250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Laviceftra 250mg Injection works:
Ceftolozane/tazobactam 250mg injection is a bacterial infection treatment that works by disrupting the bacterial cell wall's formation, thus eliminating the bacteria's protective barrier and causing its death.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concurrent use of Laviceftra 250mg Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injectable form of Laviceftra, 250mg, poses minimal to no documented threat to fetal development during gestation, according to the majority of research.
Breast feedingCAUTION
Administering Laviceftra 250mg Injection to breastfeeding mothers requires careful consideration. Discontinue breastfeeding throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administration of Laviceftra 250mg Injection can induce drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects manifest.
KidneySAFE IF PRESCRIBED
Laviceftra 250mg Injection can be administered to patients with kidney disease without altering the dosage. Nevertheless, disclosure of any pre-existing renal impairment to your physician is advised.
LiverCAUTION
Exercise caution when administering 250mg Laviceftra injections to individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alteration for Laviceftra 250mg Injection is not advised for patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Laviceftra 250mg Injection :
Omit a scheduled Laviceftra 250mg Injection? Seek your physician's advice.
Facts to Know About Laviceftra 250mg Injection
| Label | Value |
|---|---|
| Chemical Category | Extended-Spectrum Cephalosporins (Generations 3 & 4) |
| Developing Habits | No. |
| Treatment Category | Anti-infective agents |
3,018 People bought this recently